Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |